Oakland, CALIFORNIA2 Active Studies

Multiple Sclerosis Clinical Trials in Oakland, CALIFORNIA

Find 2 actively recruiting multiple sclerosis clinical trials in Oakland, CALIFORNIA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
2,056
Enrolling

Recruiting Multiple Sclerosis Studies in Oakland

About Multiple Sclerosis Clinical Trials in Oakland

Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks the protective covering of nerve fibers, causing communication problems between the brain and body. Symptoms vary widely and can include vision problems, fatigue, and mobility issues. Disease-modifying therapies have significantly improved outcomes.

There are currently 2 multiple sclerosis clinical trials recruiting participants in Oakland, CALIFORNIA. These studies are seeking a combined 2,056 participants. Research is being sponsored by Children's Oncology Group, University of Rochester NCORP Research Base. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Sclerosis Clinical Trials in Oakland — FAQ

Are there multiple sclerosis clinical trials in Oakland?

Yes, there are 2 multiple sclerosis clinical trials currently recruiting in Oakland, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Oakland?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Oakland research site will contact you about next steps.

Are clinical trials in Oakland free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Oakland studies also compensate for your time and travel.

What multiple sclerosis treatments are being tested?

The 2 active trials in Oakland are testing new therapies including novel drugs, biologics, and treatment approaches for multiple sclerosis.

Data updated March 2, 2026 from ClinicalTrials.gov